期刊文献+

大果阿魏抗凝血活性实验 被引量:1

Study on Anticoagulation Effects of Ferula lehmannii Boiss
下载PDF
导出
摘要 目的:研究大果阿魏的抗凝血作用。方法:Wistar大鼠随机分为6组,大果阿魏高剂量组100 mg·kg^(-1),中剂量组50 mg·kg^(-1),低剂量组25 mg·kg^(-1),中药阳性药物对照组银杏叶片144μg·kg^(-1),西药阳性药物对照组华法林125μg·kg^(-1),空白溶剂对照组给予等容量的生理盐水,连续灌胃7 d。测定大鼠活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、凝血酶时间(TT)及复钙时间(RT),观察大果阿魏的抗凝血作用。结果:高、中、低三个剂量组的大果阿魏均能明显延长大鼠血浆APTT、PT、TT和RT时间。与溶剂对照组比较,差异均有统计学意义(P<0.05或P<0.01)。结论:大果阿魏具有显著的抗凝血作用。 Objective : To study the effect of FerulA lehmannii Boiss on anticoagulation. Method : Wistar mice were randomly allocated to six groups. Ferula lehmannii Boiss group received the Ferula lehmannii Boiss at a dose level of 100, 50, 25 mg. kg- 1 by intragastric administration for seven days. Warfarin group was given warfarin sodium tablets at a dose level of 144 μg. kg- 1 for seven days. ginkgo leaf group was given ginkgo leaf tablets at a dose level of 125 μg.kg-1 for seven days. Control group was kept in an equal vol- ume of normal saline. AFTT, PT, TT, RT were used to evaluate the anticoagulalion activities of Ferula lehmannii Boiss. Result: Feru- la lehmannii Boiss significantly delayed APTT, PT, TT and RT. Compared with control group of NS, the difference had statistical significance (P 〈 0. 05 or P 〈 0. 01 ). Conclusion: Ferula lehmannii Boiss has obvious effect on blood antieoagulation.
出处 《中国药师》 CAS 2010年第11期1626-1628,共3页 China Pharmacist
关键词 大果阿魏 倍半萜香豆素 抗凝血 Ferula lehmannii Boiss Sesquiterpene coumarin Anticoagulation
  • 相关文献

参考文献2

二级参考文献23

  • 1周静.近年来国内植物多糖生物活性研究进展[J].中草药,1994,25(1):40-44. 被引量:50
  • 2孙姝兰,万甡,刘丹,吴明江,张丽萍.玉米芯水溶性多糖的分离纯化和抗凝血活性研究[J].分子科学学报,2006,22(2):131-134. 被引量:8
  • 3Elin S O, Kristin I. Polysaccharides fom lichens: structural characterisitics and biological activity [J]. Planta Medica, 2001,67:199 ~ 208.
  • 4Wang Z, Fang J N, Ge D L, et al. Chemical characterization and immunological activties of an acidic polysaccharide isolated from the seed of cuscuta chinensis Lam[J]. Acta Pharmacol Sin , 2000 , 21(12):1136~ 1140.
  • 5Gonze M D, Salartash K, Stembergh W C, et al. Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis [J]. Circulation, 2000, 101 (22): 2658~ 2661.
  • 6Lee B Y, et al. Amphiphilic polysaccharide derivatives[P]. U. S.P Patent, 6245753,2001: 06 ~ 12.
  • 7Jack H, Sonia S A, Jonathan L, et al. Mechanism of action and pharmacology of unfractionated heparin[J]. Arterioscler Thromb Vasc Biol,2001,21:1094 ~ 1099.
  • 8Barry N J, Dorothy G. Low-molecular- weight heparins and heparinoids[J]. Med J Aust ,2003,178(8) :413 ~ 414.
  • 9Valiukiene L, Naudziunas A, Unikauskas A. Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials) [J]. Medicina Kmu Lt,2003,39(4) :352 ~ 358.
  • 10金伟,王亚威.虻虫抗凝血物质的药理研究[J].中医药信息,2000,17(3):64-66. 被引量:36

共引文献28

同被引文献40

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部